UOB 1H26: Earnings stabilising, but a broader recovery is still needed

UOB’s 1H26 results show early signs of earnings stabilisation as the rate drag eases and wealth income grows, but weaker core revenue and rising Greater China credit risks keep the recovery uneven. Capital strength and an attractive forward dividend yield provide support, but stronger fee growth and sustained credit discipline are needed for further share price gains.

Adeline Gao Yuanhui
Adeline Gao Yuanhui13 Aug 2026 16 Views
UOB 1H26: Earnings stabilising, but a broader recovery is still needed

  • Headline profit rose 3%, but pre-provision profit fell 4%, with earnings growth supported by provision releases, associate income and one-off divestment gains while core earnings remained soft.
  • NIM is approaching a floor as SORA firms, but net fee income fell 2% on weaker loan-related and investment-banking activity.
  • Greater China remains UOB’s largest residual credit risk, with its NPL ratio rising to 4.8% and NPA coverage thinning to 42%, partly masked by general-provision releases.
  • UOB’s 15.0% CET1 ratio and 4.4% average forward dividend yield support shareholder returns, but further upside requires stronger fee growth and continued credit containment.

Headline earnings improve, but underlying momentum remains weak

UOB rounded off the 1H2026 Singapore banks reporting season with a first-half result that was resilient at the headline level, but softer beneath the surface. Net profit rose 3% year-on-year to SGD 2.92 billion, but the underlying operating picture was weaker. Total income declined 1% to SGD 7.02 billion and pre-provision operating profit fell 4% to SGD 3.87 billion. The earnings uplift was driven largely by below-the-line support, including higher contributions from associates, and non-recurring gains from asset divestments. Core revenue drivers remained under pressure, with net interest income declining 3% to SGD 4.62 billion, and net fee income fell 2% to SGD 1.30 billion as record wealth fees were offset by weaker loan-related and investment banking fees.

The second quarter, summarised in the table below, reinforces the same underlying dynamic. Quarterly net profit rose 10% year-on-year and 3% quarter-on-quarter to SGD 1.48 billion, but the sequential improvement was driven largely by non-operating gains. Taken together, the results point to a headline earnings recovery that has yet to be matched by a meaningful improvement in underlying operating momentum.

Table 1: UOB 2Q26 financial performance summary

Line Item

2Q26

YoY %

QoQ %

Net Interest Income

SGD 2.30b

-2%

-1%

Net Fee Income

SGD 665m

5%

4%

Other Non-Interest Income

SGD 632m

28%

37%

Total Income

SGD 3.60b

4%

5%

Net Profit

SGD 1.48b

10%

3%

Net Interest Margin

1.74%

-17bps

-8bps

NPL Ratio

1.60%

Unchanged

+0.1pt

Credit Costs (bps)

28bps

-6bps

+2bps

Source: UOB
Data as of 30 June 2026

Net interest income pressure is easing, but non-interest income recovery remains measured

Net interest income remains the main drag on earnings, nevertheless, the rate backdrop is now more supportive as we anticipated in our 1Q26 update. SORA has risen for three consecutive months to around 1.15% at end-July, while the Federal Reserve’s latest projections no longer point to rate cuts as the base case. With 1H26 NIM averaging 1.78%, within management’s guided 1.75%–1.80% range, and the rate drag beginning to moderate, margin pressure appears to be approaching a floor. Balance-sheet momentum also remains healthy, with gross loans up 5% year-on-year and CASA balances continuing to grow, supporting UOB’s low-cost funding base.

The next leg of earnings growth will depend increasingly on non-interest income, although the recovery remains measured. The wealth franchise continued to perform well, with first-half wealth income rising 16% year-on-year and ASEAN-4 wealth income up 30%. High-net-worth AUM reached SGD 204 billion, up 7%, supported by SGD 4 billion of net new money, while fund management fees grew 20%. The Allianz Global Investors partnership should further broaden UOB’s product offering and support the continued development of its advisory-led wealth franchise.

However, stronger wealth performance has yet to translate into broad-based fee growth. Net fee income still declined 2% in 1H26, as a 19% decline in loan-related fees and softer investment-banking activity more than offset record wealth fees. While the wealth franchise provides a structurally stronger earnings base, a broader recovery in capital-market and deal activity is still needed for non-interest income to become a more meaningful growth driver. Management has consequently lowered its full-year fee income guidance to low-single-digit growth, from high-single-digit growth previously.

Greater China credit, the risk we flagged, is becoming more pronounced

Asset quality is where the first half most clearly warrants caution. The group NPL ratio held at 1.6%, while credit costs of 27 basis points remained within management’s 25–30 basis-point guidance. However, this stability was partly supported by a release of general allowances that offset higher specific provisions, while the underlying trend in Greater China — which we identified as the clearest area of credit monitoring in our 1Q26 update — deteriorated materially. The portfolio’s NPL ratio rose to 4.8% from 3.5% in 1Q26, while NPA coverage fell to 42% from 57% following the downgrade of a closely monitored real-estate account. The Greater China portfolio therefore remains UOB’s largest residual credit risk, warranting closer monitoring in the second half given the higher NPL ratio and thinner coverage.

Related article: UOB 1Q26: The earnings base is stabilising, but stronger growth still requires better conditions

Dividend support remains solid, but stronger earnings delivery is needed

UOB trades at the lowest valuation among the three local banks, at around 1.4x forward price-to-book versus roughly 2x for OCBC and 3x for DBS. This discount reflects its lower return on equity, as well as the earnings-quality and credit considerations discussed above. Capital strength remains a clear positive, with a fully loaded Common Equity Tier 1 (CET1) ratio of 15.0%, the highest among the three banks, providing ample capacity to sustain shareholder returns.

We raise our target price to SGD 42.2, based on our adjusted 2028 estimates. With a forward dividend yield averaging around 4.4% over the next three years, UOB continues to offer steady income support. However, with near-term price upside remaining limited and the earnings recovery still gradual, further share price gains will depend increasingly on a firmer fee recovery and continued containment of Greater China credit risks. For investors yet to build a position, a more selective approach on entry valuation may be warranted given the stock’s current premium to its 10-year average price-to-book.

Table 2: Valuation table for UOB

UOB (SGX: U11)

 

2025A

2026E

2027E

2028E

EPS

2.8

3.3

3.7

4.1

EPS Growth

-26.3%

21.7%

10.1%

11.1%

P/E Ratio (X)

15.3

12.5

11.4

10.3

Book Value/Share

30.2

32.7

35.3

38.2

P/B Ratio (X)

1.1

1.3

1.2

1.1

Dividend Yield

5.4%

4.0%

4.4%

4.9%

Target Price (SGD)

42.2

Upside Potential (Excluding dividends)

0.6%

Source: Bloomberg Finance L.P., iFAST Estimates.
Data as of 12 Aug 2026

Figure 1: UOB’s share price vs earnings per share

Related articles: DBS 1H26: Strong earnings, attractive dividend, valuation catches up

OCBC 1H26: Record quarter, wealth-led growth shines, but valuation raises the bar

Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.

This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report — including all investment theses, ratings, price targets and conclusions — has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.